RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell

Dismiss alert

Acute Myeloid Leukemia



Fund Type


Maximum Award Level


Pharmacy Card Fund


Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Adriamycin
  • Ayvakit
  • Azacitidine
  • Cladribine
  • Clofarabine
  • Clolar
  • Cyclophosphamide
  • Cycophosphamide Intra Sol
  • Cytarabine
  • Cytoxan
  • Dacogen
  • Daunorubicin
  • Daurismo
  • Decitabine
  • Depocyt
  • Dexamet/nacl
  • Dexamethasone
  • Dexamethasone Sodium Phosphate
  • Dexpak
  • Doubledex
  • Doxorubicin
  • Droxia
  • Enasidenib
  • Etopophos
  • Etoposide
  • Fludarabine
  • Gemtuzumab Ozogamicin
  • Glasdegib
  • Hydrea
  • Hydroxyurea
  • Idamycin Pfs
  • Idarubicin Hydrochloride
  • Idhifa
  • Ivosidenib
  • Jakafi
  • Locort
  • Maxidex
  • Methotrexate
  • Mitoxantron
  • Mylotarg
  • Neosar
  • Nexavar
  • Nivestym
  • Onureg
  • Otrexup
  • Ozurdex
  • Rasuvo
  • Ready Dexame
  • Rezlidhia
  • Rydapt
  • Tabloid
  • Thioguanine
  • Tibsovo
  • Toposar
  • Tretinoin
  • Trexall
  • Vanflyta
  • Venclexta
  • Venetoclax
  • Vesanoid
  • Vidaza
  • Vyxeos
  • Xatmep
  • Xospata
  • Zarxio
  • Zonacort
  • Zyloprim

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of acute myeloid leukemia.

Grant Utilization

HealthWell estimates that patients use an average of $4,270 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.



About Acute Myeloid Leukemia

Acute myeloid leukemia (AML) starts in the bone marrow (the soft inner part of certain bones, where new blood cells are made), but in most cases it quickly moves into the blood. Most cases of AML develop from cells that would turn into white blood cells (other than lymphocytes), but some cases of AML develop in other types of blood-forming cells. According to the American Cancer Society (ACS), AML can sometimes spread to other parts of the body including the lymph nodes, liver, spleen, central nervous system (brain and spinal cord), and testicles. “Acute” means that this leukemia can progress quickly if not treated, and would probably be fatal in a few months. “Myeloid” refers to the type of cell this leukemia starts from. Source: American Cancer Society


Additional Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.

Close menu